ANN out:- MMJ achieves significant step towards supplying Australian medicinal cannabis market following its partner’s receipt of medicinal cannabis import licence • MMJ’s Swiss subsidiary, Satipharm AG, targeting near-term supply of cannabidiol (CBD) capsules to Australian pharmacies through strategic partnership with HL Pharma Pty Ltd • Satipharm is positioned to seek approval to supply its Gelpell CBD capsules as one of the first medicinal cannabis products available on the Australian market
Ann: Trading Halt, page-189
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.833M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118904 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 18000 | 2 |
View Market Depth
| Last trade - 10.26am 18/07/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable